PMID- 27142144 OWN - NLM STAT- MEDLINE DCOM- 20170615 LR - 20170815 IS - 1532-2777 (Electronic) IS - 0306-9877 (Linking) VI - 91 DP - 2016 Jun TI - From organophosphate poisoning to diabetes mellitus: The incretin effect. PG - 53-55 LID - S0306-9877(16)30010-X [pii] LID - 10.1016/j.mehy.2016.04.002 [doi] AB - Organophosphate (OP) poisoning induced disruption of glucose homeostasis is well established. OP poisoning leads to accumulation of acetylcholine (ACh) due to the inhibition of acetylcholinesterases (AChE). On the other hand the incidence of type 2 diabetes mellitus (T2DM) is shown to rise along with the use of pesticides in Southeast Asia. Attenuation of the 'incretin effect' is seen in T2DM. This effect is regulated by a complex loop of mechanism involving ACh driven muscarinic receptors. We hypothesize that OP poisoning leads to disruption of glucose homeostasis by attenuation of the incretin effect. Inhibition of the Glucagon Like Peptide-1 (GLP-1) secretion is our main focus of interest. Positive finding of the hypothesis will open possibility of using incretin based treatment modalities to treat or prevent acute OP induced disruption of glucose homeostasis. CI - Copyright (c) 2016 Elsevier Ltd. All rights reserved. FAU - Rathish, D AU - Rathish D AD - Department of Pharmacology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Anuradhapura, Sri Lanka. Electronic address: rathishdeva@gmail.com. FAU - Agampodi, S B AU - Agampodi SB AD - Department of Community Medicine, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Anuradhapura, Sri Lanka. FAU - Jayasumana, M A C S AU - Jayasumana MACS AD - Department of Pharmacology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Anuradhapura, Sri Lanka. FAU - Siribaddana, S H AU - Siribaddana SH AD - Department of Medicine, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Anuradhapura, Sri Lanka. LA - eng PT - Journal Article DEP - 20160407 PL - United States TA - Med Hypotheses JT - Medical hypotheses JID - 7505668 RN - 0 (Incretins) RN - 0 (Organophosphates) RN - 7C0697DR9I (Atropine) RN - 89750-14-1 (Glucagon-Like Peptide 1) RN - EC 3.1.1.7 (Acetylcholinesterase) RN - IY9XDZ35W2 (Glucose) RN - N9YNS0M02X (Acetylcholine) SB - IM MH - Acetylcholine/metabolism MH - Acetylcholinesterase/metabolism MH - Animals MH - Atropine/therapeutic use MH - Diabetes Mellitus, Type 2/*drug therapy/*prevention & control MH - Endocrine System MH - Glucagon-Like Peptide 1/metabolism MH - Glucose/metabolism MH - Homeostasis MH - Humans MH - Incretins/*metabolism MH - Models, Theoretical MH - Organophosphate Poisoning/*drug therapy MH - Organophosphates/toxicity MH - Treatment Outcome OTO - NOTNLM OT - Acetylcholine OT - Atropine OT - Glucagon Like Peptide-1 OT - Glucose homeostasis OT - Incretins OT - Organophosphate OT - Type 2 diabetes mellitus EDAT- 2016/05/05 06:00 MHDA- 2017/06/16 06:00 CRDT- 2016/05/05 06:00 PHST- 2016/01/28 00:00 [received] PHST- 2016/04/02 00:00 [accepted] PHST- 2016/05/05 06:00 [entrez] PHST- 2016/05/05 06:00 [pubmed] PHST- 2017/06/16 06:00 [medline] AID - S0306-9877(16)30010-X [pii] AID - 10.1016/j.mehy.2016.04.002 [doi] PST - ppublish SO - Med Hypotheses. 2016 Jun;91:53-55. doi: 10.1016/j.mehy.2016.04.002. Epub 2016 Apr 7.